Essay
⭐ 4.3
Artificial Intelligence Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — 2024–2026 Trends
Abstract
This essay investigates “Artificial Intelligence Adoption in Pharmaceutical Firms: Cost–Benefit Analysis — 2024–2026 Trends” using a randomized controlled trial design. Through a institutional lens, the analysis integrates multi-source data to derive a validated measurement model for researchers and practitioners.